PA
ARES icon

PharVision Advisers’s Ares Management ARES Stock Holding History

PharVision Advisers’s Portfolio ARES Stock Details ARES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,325
Closed -$214K – 131
2025
Q4 		$214K Buy
+1,325
New +$206K 0.11% 507

Other funds holding ARES

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PharVision Advisers's ARES Position: Q1 2026 in Review

PharVision Advisers sold out of Ares Management (ARES) in Q1 2026, closing a stake of 1,325 shares — an estimated $214K sold.

PharVision Advisers first reported a position in ARES in Q4 2025 and held it in 1 quarter. The position peaked at $214K in Q4 2025. 794 funds tracked by Wall St. Rank hold ARES as of Q1 2026.

  • PharVision Advisers reported no remaining Ares Management position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 1,325 Ares Management shares in Q1 2026, an estimated $214K.
  • PharVision Advisers first reported a position in Ares Management in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Ares Management position peaked at $214K in Q4 2025.
  • 794 funds tracked by Wall St. Rank held Ares Management as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.